Patent details

Basic Information

Publication number:

EP1339438

PCT Application Number:

PCT/US/2001/044481

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP019860279

PCT Publication Number:

WO/2002/043785

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PREVENTING TRANSPLANT REJECTION IN THE EYE

French Title of Invention:

PREVENTION DU REJET DE GREFFE DANS L'OEIL

German Title of Invention:

VERHINDERUNG VON TRANSPLANTATABSTOSSUNG IM AUGE

SPC Number:

Dates

Filing date:

28/11/2001

Grant date:

19/10/2005

EP Publication Date:

19/10/2005

PCT Publication Date:

06/06/2002

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

03/09/2003

EP B1 Publication Date:

19/10/2005

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

28/11/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

28/11/2001

 

 

Name:

Allergan Inc.

Address:

2525 Dupont Drive, Irvine, CA 92612, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

19/10/2005

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

Name:

WONG Vernon, G.

Address:

United States (US)

Priority

1

Priority Number:

250023 P

Priority Date:

29/11/2000

Priority Country:

United States (US)

2

Priority Number:

298253 P

Priority Date:

12/06/2001

Priority Country:

United States (US)

Classification

Main IPC Class:

A61L 27/54;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

27/11/2020

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

Computer Packages INC

Filing date	Document type	Number of pages